InsidersTradesSigma
Explore the full record of transactions filed by DiRaimondo Thomas, Chief Scientific Officer. Insider active across 1 companies, notably Janux Therapeutics, Inc.. Cumulatively, 2 disclosures have been recorded. Total volume traded: €59k. The latest transaction was filed on 2 January 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Thomas DiRaimondo is the Chief Scientific Officer at Janux Therapeutics, Inc. He oversees the company's research and development initiatives, contributing to innovation and scientific advancement. His expertise is essential for Janux.